{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T09:27:09Z","timestamp":1795166829324,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The decision to initiate pharmacotherapy is integral in the care for pregnant women with gestational diabetes mellitus (GDM). We sought to compare pregnancy outcomes between two threshold percentages of elevated glucose values prior to initiation of pharmacotherapy for GDM. We hypothesized that a lower threshold at pharmacotherapy initiation will be associated with lower rates of adverse perinatal outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study of women with GDM delivering in a single tertiary care center. Pregnancy outcomes were compared using bivariable and multivariable analyses between women who started pharmacotherapy (insulin or oral hypoglycemic agent) after a failed trial of dietary modifications at two different ranges of elevated capillary blood glucose (CBG) values: Group 1 when 20\u201339% CBG values were above goal; Group 2 when \u226540% CBG values were above goal. The primary outcome was a composite GDM-associated neonatal adverse outcome that included: macrosomia, large for gestational age (LGA), shoulder dystocia, hypoglycemia, hyperbilirubinemia requiring phototherapy, respiratory distress syndrome, stillbirth, and neonatal demise. Secondary outcomes included cesarean delivery, preterm birth (&lt;\u200937\u2009weeks), neonatal intensive care unit (NICU) admission, and small for gestational age (SGA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 417 women were included in the study. In univariable analysis, the composite neonatal outcome was statistically significantly higher in Group 2 compared to Group 1 (47.9% vs. 31.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.001). In addition, rates of preterm birth (15.7% vs 7.4%, <jats:italic>p<\/jats:italic>\u2009=\u20090.011), NICU admission (11.7% vs 4.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.006), and LGA (21.2% vs 9.1% <jats:italic>p<\/jats:italic>\u2009=\u20090.001) were higher in Group 2. In contrast, higher rates of SGA were noted in Group 1 (8.0% vs. 2.9%, <jats:italic>p<\/jats:italic>\u2009=\u20090.019). There was no difference in cesarean section rates. These findings persisted in multivariable analysis after adjusting for confounding factors (composite neonatal outcome aOR\u2009=\u20090.50, 95%CI [0.31\u20130.78]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Initiation of pharmacotherapy for GDM when 20\u201339% of CBG values are above goal, compared to \u226540%, was associated with decreased rates of adverse neonatal outcomes attributable to GDM. This was accompanied by higher rates of SGA among women receiving pharmacotherapy at the lower threshold. Additional studies are required to identify the optimal threshold of abnormal CBG values to initiate pharmacotherapy for GDM.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-020-03449-y","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:18:49Z","timestamp":1607689129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The timing of initiation of pharmacotherapy for women with gestational diabetes mellitus"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7491-716X","authenticated-orcid":false,"given":"Rachel K.","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Davitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Palatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"3449_CR1","doi-asserted-by":"crossref","unstructured":"Gestational diabetes mellitus. ACOG Practice Bulletin No. 190. American College of Obstetricians and Gynecologists. Obstet Gynecol 2018;131:e49\u2013e64.","DOI":"10.1097\/AOG.0000000000002501"},{"key":"3449_CR2","unstructured":"Lockwood, Charles J., Jay D. Iams, and Michael F. Greene. Creasy and Resnik's maternal-fetal medicine: principles and practice. Philadelphia: Elsevier Health Sciences; 2013."},{"issue":"2","key":"3449_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.7326\/0003-4819-159-2-201307160-00661","volume":"159","author":"L Hartling","year":"2013","unstructured":"Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the US preventive services task force and the National Institutes of Health Office of medical applications of research. Ann Int Med. 2013;159(2):123\u20139.","journal-title":"Ann Int Med"},{"issue":"4","key":"3449_CR4","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajog.2004.11.039","volume":"192","author":"O Langer","year":"2005","unstructured":"Langer O, Yogev Y, Most O, Xenakis EM. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192(4):989\u201397.","journal-title":"Am J Obstet Gynecol"},{"issue":"24","key":"3449_CR5","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa042973","volume":"352","author":"CA Crowther","year":"2005","unstructured":"Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477\u201386.","journal-title":"N Engl J Med"},{"issue":"14","key":"3449_CR6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","volume":"361","author":"MB Landon","year":"2009","unstructured":"Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp JM Jr, Sciscione A. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339\u201348.","journal-title":"N Engl J Med"},{"issue":"19","key":"3449_CR7","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","unstructured":"HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991\u20132002.","journal-title":"N Engl J Med"},{"issue":"3","key":"3449_CR8","doi-asserted-by":"publisher","first-page":"e92485","DOI":"10.1371\/journal.pone.0092485","volume":"9","author":"N Poolsup","year":"2014","unstructured":"Poolsup N, Suksomboon N, Amin M. Effect of treatment of gestational diabetes mellitus: a systematic review and meta-analysis. PLoS One. 2014;9(3):e92485.","journal-title":"PLoS One"},{"issue":"Supplement 1","key":"3449_CR9","doi-asserted-by":"publisher","first-page":"S137","DOI":"10.2337\/dc18-S013","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. 13. Management of diabetes in pregnancy: Standards of Medical Care in Diabetes\u20142018. Diabetes Care. 2018;41(Supplement 1):S137\u201343.","journal-title":"Diabetes Care"},{"key":"3449_CR10","volume-title":"Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evidence Report\/Technology Assessment No. 162","author":"Agency for Healthcare Research and Quality","year":"2008","unstructured":"Agency for Healthcare Research and Quality. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evidence Report\/Technology Assessment No. 162. Rockville: AHRQ; 2008."},{"key":"3449_CR11","doi-asserted-by":"crossref","unstructured":"Macrosomia. ACOG Practice Bulletin No. 216. American College of Obstetricians and Gynecologists. Obstet Gynecol 2020;135:e18\u2013e35.","DOI":"10.1097\/AOG.0000000000003606"},{"key":"3449_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/AOG.0000000000000345","volume":"124","author":"EL Duryea","year":"2014","unstructured":"Duryea EL, Hawkins JS, McIntire DD, Casey BM, Leveno KJ. A revised birth weight reference for the United States. Obstet Gynecol. 2014;124:16\u201322.","journal-title":"Obstet Gynecol"},{"key":"3449_CR13","doi-asserted-by":"crossref","unstructured":"Shoulder dystocia. Practice Bulletin No. 178. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e123\u2013e133.","DOI":"10.1097\/AOG.0000000000002043"},{"key":"3449_CR14","doi-asserted-by":"crossref","unstructured":"Postpartum hemorrhage. Practice Bulletin No. 183. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e168\u2013e186.","DOI":"10.1097\/AOG.0000000000002351"},{"key":"3449_CR15","doi-asserted-by":"crossref","unstructured":"Fetal growth restriction. ACOG Practice Bulletin No. 204.American College of Obstetricians and Gynecologists. Obstet Gynecol 2019;133:e97\u2013109.","DOI":"10.1097\/AOG.0000000000003070"},{"issue":"1","key":"3449_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0002-9378(97)70461-7","volume":"177","author":"P Garner","year":"1997","unstructured":"Garner P, Okun N, Keely E, Wells G, Perkins S, Sylvain J, Belcher J. A randomized controlled trial of strict glycemic control and tertiary level obstetric care versus routine obstetric care in the management of gestational diabetes: a pilot study. Am J Obstet Gynecol. 1997;177(1):190\u20135.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3449_CR17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"Niromanesh S, Alavi A, Sharbaf FR, Amjadi N, Moosavi S, Akbari S. Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pr. 2012;98(3):422\u20139.","journal-title":"Diabetes Res Clin Pr"},{"issue":"16","key":"3449_CR18","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJM200010193431601","volume":"343","author":"O Langer","year":"2000","unstructured":"Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343(16):1134\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"3449_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajog.2005.03.018","volume":"193","author":"GF Jacobson","year":"2005","unstructured":"Jacobson GF, Ramos GA, Ching JY, Kirby RS, Ferrara A, Field DR. Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization. Am J Obstet Gynecol. 2005;193(1):118\u201324.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"3449_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/AOG.0b013e3181c52132","volume":"115","author":"LE Moore","year":"2010","unstructured":"Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55\u20139.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"3449_CR21","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.2337\/diacare.24.11.1904","volume":"24","author":"SL Kjos","year":"2001","unstructured":"Kjos SL, Schaefer-Graf U, Sardesi S, Peters RK, Buley A, Xiang AH, Bryne JD, Sutherland C, Montoro MN, Buchanan TA. A randomized controlled trial using glycemic plus fetal ultrasound parameters versus glycemic parameters to determine insulin therapy in gestational diabetes with fasting hyperglycemia. Diabetes Care. 2001;24(11):1904\u201310.","journal-title":"Diabetes Care"},{"issue":"1","key":"3449_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/1471-2393-12-71","volume":"12","author":"P Kolu","year":"2012","unstructured":"Kolu P, Raitanen J, Rissanen P, Luoto R. Health care costs associated with gestational diabetes mellitus among high-risk women\u2013results from a randomised trial. BMC Pregnancy Childb. 2012;12(1):71.","journal-title":"BMC Pregnancy Childb."},{"issue":"3","key":"3449_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/pop.2009.12303","volume":"12","author":"Y Chen","year":"2009","unstructured":"Chen Y, Quick WW, Yang W, Zhang Y, Baldwin A, Moran J, Moore V, Sahai N, Dall TM. Cost of gestational diabetes mellitus in the United States in 2007. Popul Health Manag. 2009;12(3):165\u201374.","journal-title":"Popul Health Manag"},{"issue":"1","key":"3449_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2393-7-27","volume":"7","author":"JR Moss","year":"2007","unstructured":"Moss JR, Crowther CA, Hiller JE, Willson KJ, Robinson JS. Costs and consequences of treatment for mild gestational diabetes mellitus\u2013evaluation from the ACHOIS randomised trial. BMC Pregnancy Childb. 2007;7(1):27.","journal-title":"BMC Pregnancy Childb"},{"issue":"4","key":"3449_CR25","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/ajo.12487","volume":"56","author":"T Jeffery","year":"2016","unstructured":"Jeffery T, Petersen R, Quinlivan J. Does cardiotocography have a role in the antenatal management of pregnancy complicated by gestational diabetes mellitus? Aust NZ J Obstet Gynaecol. 2016;56(4):358\u201363.","journal-title":"Aust NZ J Obstet Gynaecol"},{"issue":"1","key":"3449_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/01.AOG.0000129239.82126.a1","volume":"104","author":"Y Yogev","year":"2004","unstructured":"Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Undiagnosed asymptomatic hypoglycemia: diet, insulin, and glyburide for gestational diabetic pregnancy. Obstet Gynecol. 2004;104(1):88\u201393.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3449_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/AOG.0b013e318190a459","volume":"113","author":"W Nicholson","year":"2009","unstructured":"Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009;113(1):193\u2013205.","journal-title":"Obstet Gynecol"},{"issue":"5","key":"3449_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ajog.2010.06.044","volume":"203","author":"JS Dhulkotia","year":"2010","unstructured":"Dhulkotia JS, Ola B, Fraser R, Farrell T. Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis. Am J Obstet Gynecol. 2010;203(5):457\u2013e1.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"3449_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9378(89)90371-2","volume":"161","author":"O Langer","year":"1989","unstructured":"Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus-how tight is tight enough: small for gestational age versus large for gestational age? Am J Obstet Gynecol. 1989;161(3):646\u201353.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"3449_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ajog.2010.11.039","volume":"204","author":"PM Catalano","year":"2011","unstructured":"Catalano PM, Hauguel-De MS. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011;204(6):479\u201387.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"3449_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2337\/diacare.17.7.640","volume":"17","author":"R Schwartz","year":"1994","unstructured":"Schwartz R, Gruppuso PA, Petzold K, Brambilla D, Hiilesmaa V, Teramo KA. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care. 1994;17(7):640\u20138.","journal-title":"Diabetes Care"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-020-03449-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-020-03449-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:24:04Z","timestamp":1607689444000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-020-03449-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3449"],"URL":"https:\/\/doi.org\/10.1186\/s12884-020-03449-y","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"2 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prior to study initiation, institutional review board approval was obtained through the Medical College of Wisconsin (ID: PRO00031332). Through this process, we were given permission to review and collect information from the medical records.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"773"}}